Bruce McManus is Professor, Department of Pathology and Laboratory Medicine, the University of British Columbia. He serves as Co-Director, Institute for Heart + Lung Health, and as CEO, Centre of Excellence for Prevention of Organ Failure (PROOF Centre).
Dr. McManus received BA and MD degrees (University of Saskatchewan), an MSc (Pennsylvania State University), and the PhD (University of Toledo). He pursued post-doctoral fellowships at the University of California – Santa Barbara (Environmental Physiology) and at the National Heart, Lung, and Blood Institute, Bethesda, MD (Cardiovascular & Pulmonary Pathology), and residency training at the Peter Bent Brigham Hospital – Harvard University (Internal Medicine and Pathology). Dr. McManus joined the Faculty of Medicine of the University of British Columbia as Department Head of Pathology and Laboratory Medicine in 1993, serving until 2000. He served as inaugural Scientific Director of the Institute of Circulatory and Respiratory Health, Canadian Institutes of Health Research from 2000 to 2006.
Dr. McManus’ investigative passion relates to mechanisms, consequences, detection and prevention of injury and aberrant repair in inflammatory diseases of the heart, blood vessels and lungs. His program of translational work is focused on blood-based “omic” biosignature development to allow prevention and better treatment of vital organ failure. In this regard, his team of computational scientists, biologists and clinicians acquire and interrogate large diverse data sets.
Dr. McManus has convened many public-private partnerships in research and for commercialization. In recognition of his work in the life sciences, Dr. McManus was recipient of the Max Planck Research Award, was elected to the Royal Society of Canada as a Fellow of the Academy of Sciences and was elected as an inaugural Fellow of the Canadian Academy of Health Sciences. Dr. McManus has received the BC Innovation Council’s Lieutenant Governor’s Technology Innovation Award. In 2012 he received the Milton Wong Leadership Award from LifeSciences BC and the Aubrey J Tingle Prize from the Michael Smith Foundation for Health Research.